Published in Transfusion on March 24, 2011
Diagnosis and management of nonvariceal upper gastrointestinal bleeding. Nat Rev Gastroenterol Hepatol (2012) 1.06
Restrictive vs liberal blood transfusion for acute upper gastrointestinal bleeding: rationale and protocol for a cluster randomized feasibility trial. Transfus Med Rev (2013) 0.95
Update on the transfusion in gastrointestinal bleeding (TRIGGER) trial: statistical analysis plan for a cluster-randomised feasibility trial. Trials (2013) 0.93
State-of-the-art management of acute bleeding peptic ulcer disease. Saudi J Gastroenterol (2013) 0.79
Discharge hemoglobin and outcome in patients with acute nonvariceal upper gastrointestinal bleeding. Endosc Int Open (2016) 0.75
Red Blood Cell Transfusions and Iron Therapy for Patients Presenting with Acute Upper Gastrointestinal Bleeding: A Survey of Canadian Gastroenterologists and Hepatologists. Can J Gastroenterol Hepatol (2016) 0.75
Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med (2011) 6.13
Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit. Gut (2011) 4.79
Mucosal healing in inflammatory bowel diseases: a systematic review. Gut (2012) 3.02
A no-prophylaxis platelet-transfusion strategy for hematologic cancers. N Engl J Med (2013) 2.90
Use of endoscopy for management of acute upper gastrointestinal bleeding in the UK: results of a nationwide audit. Gut (2010) 2.82
IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med (2011) 2.74
Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals. Lancet (2013) 2.37
Malignancy and mortality in people with coeliac disease: population based cohort study. BMJ (2004) 2.29
Helicobacter pylori "test and treat" or endoscopy for managing dyspepsia: an individual patient data meta-analysis. Gastroenterology (2005) 2.07
Mortality in inflammatory bowel disease: a population-based cohort study. Gastroenterology (2003) 1.83
Mortality associated with Barrett's esophagus and gastroesophageal reflux disease diagnoses-a population-based cohort study. Am J Gastroenterol (2005) 1.79
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics. Am J Gastroenterol (2010) 1.74
TUCAN (CARD8) genetic variants and inflammatory bowel disease. Gastroenterology (2006) 1.73
End-to-end electronic control of the hospital transfusion process to increase the safety of blood transfusion: strengths and weaknesses. Transfusion (2006) 1.71
Weight loss at high altitude: pathophysiology and practical implications. Eur J Gastroenterol Hepatol (2006) 1.68
A common CTLA4 haplotype associated with coeliac disease. Eur J Hum Genet (2005) 1.65
Fracture risk in people with celiac disease: a population-based cohort study. Gastroenterology (2003) 1.63
Outcome measurement in clinical trials for Ulcerative Colitis: towards standardisation. Trials (2007) 1.62
Validity of the Rockall scoring system after endoscopic therapy for bleeding peptic ulcer: a prospective cohort study. Gastrointest Endosc (2006) 1.60
Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch. Pharmacogenetics (2004) 1.49
Brief review: Supplementing oxygen through an airway exchange catheter: efficacy, complications, and recommendations. Can J Anaesth (2011) 1.48
Factors affecting red blood cell storage age at the time of transfusion. Transfusion (2013) 1.47
Rank minimization with a two-step analysis should not replace randomization in clinical trials. J Clin Epidemiol (2012) 1.44
The difficult airway with recommendations for management--part 2--the anticipated difficult airway. Can J Anaesth (2013) 1.42
Immunoplatelet counting: potential for reducing the use of platelet transfusions through more accurate platelet counting. Br J Haematol (2003) 1.39
Clinical controversies: etomidate as an induction agent for endotracheal intubation in patients with sepsis: continue to use etomidate for intubation of patients with septic shock. Ann Emerg Med (2008) 1.30
Concepts of blood transfusion in adults. Lancet (2013) 1.28
Obstructing giant post-inflammatory polyposis in ulcerative colitis: Case report and review of the literature. J Crohns Colitis (2008) 1.28
A basal gradient of Wnt and stem-cell number influences regional tumour distribution in human and mouse intestinal tracts. Gut (2012) 1.16
Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN. Am J Gastroenterol (2011) 1.16
The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: safety. Am J Gastroenterol (2011) 1.15
Prevalence of maternal anaemia and its predictors: a multi-centre study. Eur J Obstet Gynecol Reprod Biol (2011) 1.14
The difficult airway with recommendations for management--part 1--difficult tracheal intubation encountered in an unconscious/induced patient. Can J Anaesth (2013) 1.08
The pattern and outcome of acute severe colitis. J Crohns Colitis (2010) 1.06
Red cell transfusion for the management of upper gastrointestinal haemorrhage. Cochrane Database Syst Rev (2010) 1.05
European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia. Br J Haematol (2003) 1.05
New strategies for the optimal use of platelet transfusions. Hematology Am Soc Hematol Educ Program (2008) 1.04
Ornithine decarboxylase G316A genotype is prognostic for colorectal adenoma recurrence and predicts efficacy of aspirin chemoprevention. Clin Cancer Res (2008) 1.04
Long-term mortality in people with celiac disease diagnosed in childhood compared with adulthood: a population-based cohort study. Am J Gastroenterol (2007) 1.04
Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation. Cochrane Database Syst Rev (2012) 1.03
Pathogen-reduced platelets for the prevention of bleeding. Cochrane Database Syst Rev (2013) 1.02
Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment. Dis Colon Rectum (2006) 1.01
The role of CMV in steroid-resistant ulcerative colitis: A systematic review. J Crohns Colitis (2009) 1.00
What is the maximum time that a unit of red blood cells can be safely left out of controlled temperature storage? Transfus Med Rev (2011) 0.99
Medical management of Crohn's disease. BMJ (2008) 0.97
Cholesterol profile in people with newly diagnosed coeliac disease: a comparison with the general population and changes following treatment. Br J Nutr (2009) 0.95
Genetic variants of UGT1A6 influence risk of colorectal adenoma recurrence. Clin Cancer Res (2006) 0.95
Restrictive vs liberal blood transfusion for acute upper gastrointestinal bleeding: rationale and protocol for a cluster randomized feasibility trial. Transfus Med Rev (2013) 0.95
Update on the transfusion in gastrointestinal bleeding (TRIGGER) trial: statistical analysis plan for a cluster-randomised feasibility trial. Trials (2013) 0.93
The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions. Transfusion (2013) 0.91
Dairy products, polymorphisms in the vitamin D receptor gene and colorectal adenoma recurrence. Int J Cancer (2008) 0.90
Challenges and opportunities to prevent transfusion errors: a Qualitative Evaluation for Safer Transfusion (QUEST). Transfusion (2012) 0.90
Red blood cell transfusion for people undergoing hip fracture surgery. Cochrane Database Syst Rev (2015) 0.89
Prevalence, management, and outcomes of patients with coagulopathy after acute nonvariceal upper gastrointestinal bleeding in the United Kingdom. Transfusion (2012) 0.89
What is the peak age for onset of IBD? Inflamm Bowel Dis (2008) 0.89
Why do mortality rates for nonvariceal upper gastrointestinal bleeding differ around the world? A systematic review of cohort studies. Can J Gastroenterol (2012) 0.89
Folate metabolism polymorphisms influence risk of colorectal adenoma recurrence. Cancer Epidemiol Biomarkers Prev (2006) 0.88
Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders. Cochrane Database Syst Rev (2013) 0.88
Biosimilars in IBD: hope or expectation? Gut (2013) 0.88
Impact of a nurse-led counselling service on quality of life in patients with inflammatory bowel disease. J Adv Nurs (2002) 0.88
The incidence and outcomes of fetomaternal alloimmune thrombocytopenia: a UK national study using three data sources. Br J Haematol (2011) 0.87
Choosing sensitivity analyses for randomised trials: principles. BMC Med Res Methodol (2014) 0.86
Thiopurine therapy: when to start and when to stop. Eur J Gastroenterol Hepatol (2003) 0.86
HPA-1a phenotype-genotype discrepancy reveals a naturally occurring Arg93Gln substitution in the platelet beta 3 integrin that disrupts the HPA-1a epitope. Blood (2002) 0.86
Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- the ATHENA study. Br J Haematol (2014) 0.86
The iceberg of celiac disease: what is below the waterline? Clin Gastroenterol Hepatol (2007) 0.86
Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial. Transfusion (2014) 0.86
What is the optimal treatment for anemia in inflammatory bowel disease? Curr Drug Deliv (2012) 0.85
Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis. Clin Gastroenterol Hepatol (2011) 0.85
Measurement of phosphatidylserine exposure during storage of platelet concentrates using the novel probe lactadherin: a comparison study with annexin V. Transfusion (2008) 0.85
Small-area analyses of bone cancer diagnosed in Great Britain provide clues to aetiology. BMC Cancer (2012) 0.84
Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial. Int J Cancer (2007) 0.84
Markers of platelet activation and apoptosis during storage of apheresis- and buffy coat-derived platelet concentrates for 7 days. Transfusion (2008) 0.84
Polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers: seeking confirmation of the association in a follow-up study. Pharmacogenetics (2002) 0.84
Antenatal interventions for fetomaternal alloimmune thrombocytopenia. Cochrane Database Syst Rev (2011) 0.84
Sex and gender in adverse drug events, addiction, and placebo. Handb Exp Pharmacol (2012) 0.83
Standardizing care and monitoring for anesthesia or procedural sedation delivered outside the operating room. Curr Opin Anaesthesiol (2010) 0.83
Post menopausal hormone replacement therapy and risk of acute myocardial infarction--a case control study of women in the East Midlands, UK. Eur Heart J (2003) 0.83
The European consensus on ulcerative colitis: new horizons? Gut (2008) 0.83
Retraction. Science (2002) 0.82
Comparison between prospective and retrospective evaluation of Crohn's disease activity index. Am J Gastroenterol (2005) 0.82
Red cell transfusion management for patients undergoing cardiac surgery for congenital heart disease. Cochrane Database Syst Rev (2014) 0.81